GI Illness

Feature Article

Common Cause of GI Illness Noted to be Highly Resistant to Antimicrobials

Common Cause of GI Illness Noted to be Highly Resistant to Antimicrobials

Antibiotic resistance to Salmonella is a serious concern for public health and clinical providers.

The relative risk for healthcare-associated infections has decreased in the last 15 years due to improvements in awareness of risk associated with devices, infection control, and evidence-based practice regarding use of devices.

Latest News

Strategies for Increasing Hepatocellular Carcinoma Screening

Strategies for Increasing Hepatocellular Carcinoma Screening

Outreach strategies doubled the percentage of patients with cirrhosis who underwent ultrasound screening for HCC.

GI Inflammation Linked to Type 1 Diabetes

GI Inflammation Linked to Type 1 Diabetes

Duodenal mucosa in type 1 diabetes present with disease-specific abnormalities and inflammation, according to researchers.

Is There a Link Between Enterovirus and Pediatric Type 1 Diabetes?

Is There a Link Between Enterovirus and Pediatric Type 1 Diabetes?

Frequent enterovirus infection has been linked to type 1 diabetes in children.

Elevated Bacterial Gastroenteritis Risk With Acid Suppression Drugs

Elevated Bacterial Gastroenteritis Risk With Acid Suppression Drugs

Higher rates of both Clostridium difficile- and Campylobacter- positive gastroenteritis were seen in both community and hospital settings.

H pylori Recurrence Low One Year After Eradication

H pylori Recurrence Low One Year After Eradication

Risk factors for recurrence were peptic ulcer, contact with infected people, and hospitalization.

GBS Screening Not Cost-Effective in Repeat Cesarean Delivery

GBS Screening Not Cost-Effective in Repeat Cesarean Delivery

Universal group B streptococci screening in women with a singleton pregnancy planning a repeat cesarean delivery may not be cost-effective in all populations.

FDA: New Data for Avycaz in Complicated UTI To Be Reviewed

FDA: New Data for Avycaz in Complicated UTI To Be Reviewed

FDA has accepted a supplemental New Drug Application (sNDA) for Avycaz for the addition of new Phase 3 data to the label.

Intrahepatic Lipid Content Reduced With Physical Activity

Intrahepatic Lipid Content Reduced With Physical Activity

For patients with NAFLD, physical activity might lower intrahepatic lipid content and markers of hepatocellular injury.

Enteropathogen Testing and Diarrhea Incidence

Enteropathogen Testing and Diarrhea Incidence

The burden of moderate-to-severe diarrhea on developing countries has been underestimated by previous research.

Researchers Test the 5-Second Rule

Researchers Test the 5-Second Rule

Rutgers University researchers examined the reality of the famed 5 second rule.

Sign Up for Free e-newsletters